Search General Info
Search Education
Search Partnering Companies


NAPLES, Florida, United States
Dr. Thibonnier received his M.D. from the University of Paris and his M.Sc. in Pharmacology from UCSF where he completed his fellowship in clinical pharmacology.
He has held faculty positions in Paris, UCSF, and CWRU where he was a tenured Professor of Medicine and Pharmacology. He was a Clinical Professor of Medicine at Stanford University until 2015.
Dr. Thibonnier conducted basic and clinical research on vasoactive hormones and their receptors, supported by the AHA, the VA and the NIH ($21,554,542 in funding). He also completed clinical trials in the field of HTN, dyslipidemia and diabetes supported by various pharmaceutical sponsors and the NIH (ACCORD Trial). He has published 153 scientific articles.Thereafter, Dr. Thibonnier spent 14 years in senior executive leadership positions at major Pharmaceutical (Bayer Health Care, BMS, and GSK) and two Biotechnology Companies in the USA.
In 2012, Dr. Thibonnier founded AptamiR to tackle the the obesity pandemic and related disorders.
Speaking In
[Available On-Demand]
AptamiR Therapeutics, Inc. is a biotechnology company focused on developing revolutionary…